John Donofrio Jr. - Dec 21, 2022 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Director
Signature
/s/ Joshua Disbrow as attorney-in-fact for John Donofrio, Jr.
Stock symbol
AYTU
Transactions as of
Dec 21, 2022
Transactions value $
$0
Form type
4
Date filed
12/23/2022, 04:40 PM
Next filing
Aug 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AYTU Common Stock Disposed to Issuer $0 -188K -92.48% $0.00 15.3K Dec 21, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 21, 2022, the reporting person and the Issuer determined to rescind 187,804 vested shares of restricted common stock originally granted to the reporting person on April 16, 2021. The vesting of the remaining restricted shares remains unchanged with 1/12 vesting on the first day of each quarterly anniversary of the grant, such that the restricted shares will be fully vested on the third anniversary of the grant, subject to the reporting person's continued service with the Issuer.

Remarks:

Exhibit 24.1 Power of Attorney